Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell‐Based Therapeutics
Advanced Science · 2024
DOI: 10.1002/advs.202404172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Weilin Hou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212003, P. R. China. Hauptthemen laut MEDLINE: Hydrogels. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Key Research and Development Program of Zhenjiang.
Abstract (Originalsprache)
Smart drug platforms based on spatiotemporally controlled release and integration of tumor imaging are expected to overcome the inefficiency and uncertainty of traditional theranostic modes. In this study, a composite consisting of a thermosensitive hydrogel (polyvinyl alcohol‐carboxylic acid hydrogel (PCF)) and a multifunctional nanoparticle (Fe 3 O 4 @Au/Mn(Zn)‐4‐carboxyphenyl porphyrin/polydopamine (FAM x P)) is developed to combine tumor immunogenic cell death (ICD)/immune checkpoint blockade (ICB) therapy under the guidance of magnetic resonance imaging (MRI) and fluorescence imaging (FI). It can not only further recognize the target cells through the folate receptor of tumor cells, but also produce thermal dissolution after exposure to near‐infrared light to slowly release FAM x P in situ, thereby prolonging the treatment time and avoiding tumor recurrence. As FAM x P entered the tumor cells, it released FAM x in a pH‐dependent manner. Chemodynamic, photothermal and photodynamic therapy can cause significant ICD in cancer cells. ICB can thus be further enhanced by injecting anti‐programmed cell death ligand 1, improving the effectiveness of tumor treatment. The developed PCF‐FAM x P composite hydrogel may represent an updated drug design approach with simple compositions for cooperative MRI/FI‐guided targeted therapeutic pathways for tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212003, P. R. China.
- Central-Southern Safety and Environmental Technology Institute Co. Ltd., Wuhan, 430071, P. R. China.
- School of Chemistry, The University of New South Wales, Sydney, NSW, 2052, Australia.
- Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543, Singapore.
ORCID-Profile: Wei Shen, Sheng Tang
Förderung
- Natural Science Foundation of Jiangsu Province
- Key Research and Development Program of Zhenjiang
Zitieren
APA
Hou, W., Mao, W., Sun, J., Liu, Z., Shen, W., Lee, H. K., & Tang, S. (2024). Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell‐Based Therapeutics. Advanced Science. https://doi.org/10.1002/advs.202404172
Vancouver
Hou W, Mao W, Sun J, Liu Z, Shen W, Lee HK, et al. Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell‐Based Therapeutics. Advanced Science. 2024. doi:10.1002/advs.202404172
BibTeX
@article{Hou2024,
author = {Hou, Weilin and Mao, Wei and Sun, Jun and Liu, Zhiqiang and Shen, Wei and Lee, Hian Kee and Tang, Sheng},
title = {Targeting Hydrogel for Intelligent Recognition and Spatiotemporal Control in Cell‐Based Therapeutics},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202404172}
}
EUVIMED